Emerald Health Therapeutics Quebec Facility Gets Processing License

Cannabis Investing News

Emerald Health Therapeutics announced its Québec facility, called Verdélite, obtained a standard processing license from Health Canada.

Emerald Health Therapeutics (TSXV:EMH,OTCQX:EMHTF) announced its Québec facility, called Verdélite, obtained a standard processing license from Health Canada.

As quoted in the press release:

This license means that, in addition to Verdélite’s right to cultivate and sell cannabis flowers, it can now extract, manufacture, synthesize, test and sell next-generation cannabis products and will position Verdélite to launch these products in conjunction with the expected legalization of a broader spectrum of cannabis products in Canada in October 2019. The license also allows Verdélite to build and operate a laboratory for research and development of cannabis-based products.

“The ability to carry out research and development on cannabis, and to extract cannabinoids and manufacture next-generation cannabis products are important steps forward for Verdélite,” said Thierry Schmidt, President of Verdélite. “This processing license will allow us to develop and offer a wide-range of high-quality cannabis products, advance Verdélite and Emerald brands, and to serve recreational and medicinal consumers in Quebec and throughout Canada.

Click here to read the full press release.

The Conversation (0)
×